ETF Daily News3d
BMO Capital Markets Initiates Coverage on Avidity Biosciences (NASDAQ:RNA)
BMO Capital Markets assumed coverage on shares of Avidity Biosciences (NASDAQ:RNA – Free Report) in a research note issued to investors on Wednesday, MarketBeat Ratings reports. The brokerage ...
ETF Daily News3d
BMO Capital Markets Begins Coverage on Rocket Pharmaceuticals (NASDAQ:RCKT)
BMO Capital Markets assumed coverage on shares of Rocket Pharmaceuticals (NASDAQ:RCKT – Free Report) in a report released on Wednesday morning, MarketBeat Ratings reports. The brokerage issued ...
Yahoo Finance6d
BMO Capital Initiates Coverage on Dyne Therapeutics With Outperform Rating
BMO Capital Markets initiated coverage on Dyne Therapeutics (DYN, Financials) with an Outperform rating and a $50 price target, suggesting a strong upside from the company's current share price of ...
Lack of follow-through in post-CPI Treasury rally shows traders focused on tariff fears: strategist
A cooler-than-expected February consumer-price index is stoking a relief bounce in stock-index futures and triggered an initial surge higher in Treasurys, which pulled down yields, which move opposite ...
Yahoo Finance22d
Century Aluminum “well positioned” to benefit from tariffs, BMO upgrades stock
Investing.com -- BMO Capital Markets upgraded Century Aluminum Company (NASDAQ:CENX) to "Outperform" from "Market Perform" given its favourable valuation following a recent sell-off and the ...
Okta price target raised to $130 from $105 at BMO Capital
BMO Capital raised the firm’s price target on Okta (OKTA) to $130 from $105 and keeps a Market Perform rating on the shares. The firm had been ...
SailPoint initiated with an Outperform at BMO Capital
BMO Capital analyst Keith Bachman initiated coverage of SailPoint (SAIL) with an Outperform rating and $26 price target The firm believes ...